Home > Drug Search >
  • company_query: Bioleaders Corporation
  •   > 
Drug Filter
Category:
chemistry (3) biology (34)
Status:
Approved (5) BLA Filing (2) Phase Ⅲ (11) Phase Ⅱ (8) Phase Ⅰ (11)
Clinical Stage:
Pending (1) Active (29) Discontinued (2)
Bio-Type:
Cell therapy (2) Vaccine (24) Blood extraction (2) Allergen extract (1) Animal extract (1) Whole antibody (1) Fusion protein (1)
Indication:
Allergic rhinoconjunctivitis (1) Cystic fibrosis (CF) (1) Deep vein thrombosis (DVT) (1) Cholera (1) Rheumatic disorders (1) HBV infection (2) HIV infection (1) Influenza virus infection (2) Rabies (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) HEV infection (1) Measles (3) Mumps (2) Rubella (2) Diphtheria (4) Haemophilus infection (2) Pertussis (4) Prostate cancer (1) Poliomyelitis (1) Tetanus (6) Varicella zoster virus infections (3) Seasonal allergic rhinitis (1) Solid tumours (3) Rotavirus infection (1) Typhoid (1) Venous thromboembolism (VTE) (1) Cervical intraepithelial neoplasia (1) Unstable angina (1) Cervical carcinoma (1) Malaria (1) Condylomata acuminata (1) High-grade cervical intraepithelial neoplasia (1) Human papillomavirus infections (HPV) (1) Cervical dysplasia (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top